Global Peptide Receptor Radionuclide Therapy (PRRT) Industry Set to Surge to US$1.3 Billion by 2033 at an Impressive CAGR of 8.2%, Fueled by Growing Demand for Targeted Cancer Therapies

Future Market Insights Inc. (FMI) predicts a significant growth trajectory for the Global Peptide Receptor Radionuclide Therapy (PRRT) Industry in a groundbreaking new report. The market is poised for a remarkable rise, reaching an estimated US$1.3 billion by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 8.2% over the next decade (2023-2033). This …

Global Peptide Receptor Radionuclide Therapy (PRRT) Industry Set to Skyrocket, Anticipated to Hit US$ 1.3 Billion by 2033 at a Phenomenal CAGR of 8.2% | FMI

The Global Peptide Receptor Radionuclide Therapy (PRRT) Industry is poised for a remarkable surge, with a projected value of US$ 591.83 million in 2023, escalating to an impressive US$ 1.3 billion by 2033, according to the latest market analysis conducted by Future Market Insights Inc. This projection indicates a robust Compound Annual Growth Rate (CAGR) …

Global Peptide Receptor Radionuclide Therapy (PRRT) Industry Predicted to Hit US$ 1.3 Billion by 2033 | Insights by FMI

The Global Peptide Receptor Radionuclide Therapy (PRRT) Industry is on the cusp of substantial growth, with a projected value of US$ 591.83 million in 2023. According to the latest market analysis, this figure is anticipated to soar to an impressive US$ 1.3 billion by 2033. The forecast also reveals a robust Compound Annual Growth Rate (CAGR) of …